(Update) Acalabrutinib in CLL and MCL
Update Venetoclax in CLL
Zanubrutinib
Acalabrutinib
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
NCCN Guidelines for Patients
NCCN COVID-19 Resources Page
ASCO: COVID-19 Medical Resources